Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // November 21st, 2008 // 7:21 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that PDI, a contract sales organization, hired Nancy Lurker, 50, as ceo and also appointed her to its board. Previously, Lurker was senior vp and chief marketing officer at Novartis, and before that, ceo at ImpactRx, a market research firm, and traveled through Pharmacia and Bristol-Myers Squibb.
Elan hired Lilly exec Carlos Paya as president;
etrials Worldwide named Denis Connaghan as ceo and president;
Varian Medical named Venkatraman Thyagarajan to its board;
Ascent Therapeutics appointed Fred Jones as ceo and president;
Advanced Proteome says Robert Bender and Russ Phares resigned from its board;
Wyeth named Mike Kamarck as president of technical ops and product supply;
Compugen appointed Martin Gerstel as ceo;
ZymoGenetics promoted Doug Williams to ceo;
Middlebrook Pharma hired Frank Koos as senior vp, sales & biz development;
WorldCare Clinical hired John Tomera as director of regulatory affairs;
Ferring Pharma promoted Bill Garbarini Jr. to vp of orthopaedics and urology biz;
Clinilabs named Howard Greenberg as senior medical director of clinical pharmacology;
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Advanced Proteome Therapeutics, Clinilabs, Compugen, Elan, etrials Worldwide, Ferring Pharmaceuticals, Middlebrook Pharmaceuticals, Nancy Lurker, PDI, Varian Medical Systems, WorldCare Clinical, Wyeth, ZymoGenetics